Manufacturing and Production

Showing 15 posts of 5859 posts found.

sean_bohen

AstraZeneca’s chief medical officer announces resignation amid wave of departures

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …
nve00002_web

Living with Alström syndrome

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alström syndrome, patient experience, pharma, rare disease

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, Shire, Takeda, bristol myers squibb, death row, pharma, top 10

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …
fmilogo

Foundation medicine name Roche SVP as new CEO

January 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche subsidiary, Foundation Medicine, today announced the appointment of Roche’s senior vice president in global oncology, Cindy Perettie as the …
astrazeneca-sign

AstraZeneca to shut down twin Colorado manufacturing sites, impacting over 200 jobs

January 10, 2019 Manufacturing and Production AstraZeneca, US, job cuts, pharma

UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …
16792957331_d9572dbdf4_z

FDA approves record breaking 971 generic drugs in 2018

January 10, 2019 Manufacturing and Production FDA, approval, generic drugs, generics, regulation

The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in …

Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk

January 9, 2019 Manufacturing and Production, Research and Development India, Pfizer, pharma

Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …
nicola_redfern

bluebird bio reveals new UK General Manager

January 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma

bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions,  has named Nicola Redfern …
jose_baselga

AstraZeneca hire controversial cancer doc to head new Oncology R&D unit

January 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
heart-2372134_640

Two biomarkers can aid in atrial fibrillation screening, researchers find

January 8, 2019 Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …

Government unveils £20bn plan to revitalise NHS in England

January 8, 2019 Manufacturing and Production NHS funding, NHS< funding, brexit, government, health, policy

Theresa May and the chief executive of NHS England, Simon Stevens, have announced a new ten year plan for the …
takeda_global_hq

Takeda completes Shire acquisition

January 8, 2019 Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma

Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …
abbvie_0

AbbVie records an estimated $4billion in impairment charges after failure of cancer drug Rova-T

January 8, 2019 Manufacturing and Production AbbVie, M&A, MA, Stemcentrx, acquisition, rova-t

US firm AbbVie has said that it will record an estimated $4 billion in impairment charges related to the abandonment …
jallal

Immunocore names AstraZeneca exec as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …
mark_mallon

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …
The Gateway to Local Adoption Series

Latest content